Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

792 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva

NCT00274066

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Twenteborg Ziekenhuis Almelo, Netherlands
  • Amphia Ziekenhuis Breda, Netherlands
  • Boehringer Ingelheim Investigational Site Groningen, Netherlands
  • Afdeling longziekten Winschoten, Netherlands
View Trial Details
Completed

Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD

NCT00274040

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Chungnam National University Hospital Daejeon, South Korea
  • Jeonbuk National University Hospital Jeonju, South Korea
  • Jeonnam National University Hospital Kwangju, South Korea
  • Pusan University Hospital Pusan, South Korea
View all 18 locations
View Trial Details
Completed

High Dose Trial in COPD

NCT00128440

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Lakewood, California, United States
  • Boehringer Ingelheim Investigational Site Wheat Ridge, Colorado, United States
  • Boehringer Ingelheim Investigational Site Pembroke Farms, Florida, United States
  • Boehringer Ingelheim Investigational Site Coeur d'Alene, Idaho, United States
View all 13 locations
View Trial Details
Completed

A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00292448

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Akita, Akita, Japan
  • Boehringer Ingelheim Investigational Site Bunkyo-ku, Tokyo, Japan
  • Boehringer Ingelheim Investigational Site Bunkyo-ku,Tokyo, Japan
  • Boehringer Ingelheim Investigational Site Habikino, Osaka, Japan
View all 27 locations
View Trial Details
Completed

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate Combination

NCT01321463

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Pfizer Investigational Site Mobile, Alabama, United States
  • Pfizer Investigational Site Glendale, Arizona, United States
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site Clearwater, Florida, United States
View all 74 locations
View Trial Details

Related conditions